{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-003501","form_type":"8-K","ticker":"CLDI","cik":"0001855485","company_name":"Calidi Biotherapeutics, Inc.","filed_at":"2025-04-10T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.189799+00:00","generated_at":"2026-05-23T17:29:14.692404+00:00","sec_items":["7.01","9.01"],"event_type":"leadership","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Calidi Biotherapeutics appoints Dr. Guy Travis Clifton as Chief Medical Officer, Consultant and Advisor","bullets":["Appointment effective April 8, 2025; one-year term with monthly consulting fee of $20,833.33.","Dr. Clifton is a practicing surgical oncologist with 17+ years experience, previously CMO at Parthenon Therapeutics.","Appointment coincides with recently filed IND for CLD-201 dose escalation trial in solid tumors.","Dr. Clifton has over 80 peer-reviewed publications and served as U.S. Army Colonel with four Afghanistan deployments."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-003501","json":"https://secwatch.observer/filing/0001641172-25-003501.json","markdown":"https://secwatch.observer/filing/0001641172-25-003501.md","text":"https://secwatch.observer/filing/0001641172-25-003501.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225003501/0001641172-25-003501-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855485/000164117225003501/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T17:29:14.692404+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}